reports
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2...
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue PONTE VEDRA, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced its preliminary, unaudited fourth quarter and full-year 2024 results. Highlights: Preliminary revenue of $68.4 million to $68.8 million in the fourth quarter of 2024, an approximate 10% increase at the...
GrafTech Announces Cooperation Agreement with Stockholder Nilesh Undav...
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) today announced that it has entered into a cooperation agreement (the “Cooperation Agreement”) with one of the Company’s largest stockholders, Mr. Nilesh Undavia, who owns approximately 6.7% of the Company’s outstanding common stock. Pursuant to the Cooperation Agreement, GrafTech has appointed Sachin Shivaram to the Board of Directors of the Company (the “Board”), effective immediately. Additionally, GrafTech and Mr. Undavia will work together to identify a mutually agreed upon in...
GrafTech Announces Fourth Quarter and Full Year 2024 Earnings Conferen...
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE:EAF) (the “Company”) will hold its Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on Friday, February 7, 2025 at 10:00 a.m. (EST). The call will be hosted by senior management to discuss financial results for the fourth quarter and year ended December 31, 2024 and current business initiatives. These financial results will be released on Friday, February 7, 2025 before market open and will be available on our investor relations website at: . The conference call dial-in number is +1 (800) 717-17...
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced that John T. Treace, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, beginning at approximately 9:00 am PT. A live webcast and replay of the fir...
CompoSecure Announces Plan to Spin-Off Resolute Holdings Management, I...
CompoSecure Announces Plan to Spin-Off Resolute Holdings Management, Inc. to Form a Differentiated Alternative Asset Management Platform and Accelerate Value Enhancing Acquisitions for CompoSecure CompoSecure to enter into a Management Agreement with Resolute Holdings Pro rata distribution of shares in Resolute Holdings to all existing shareholders of CompoSecureSpin-off designed to accelerate value enhancing acquisitions for CompoSecure David Cote will be Executive Chairman and Tom Knott will be CEO of Resolute HoldingsTransaction is expected to be taxable for both CompoSecure and all exis...
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS...
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure Positions Treace to Significantly Increase Share of Overall Bunion Market and Expand Surgeon Customer Base PONTE VEDRA, Fla., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced the limited market release ...
GrafTech Announces Expiration and Final Result of the Exchange Offers ...
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) announced today the final results of the previously announced separate offers to exchange (each an “Exchange Offer” and, together, the “Exchange Offers”) by GrafTech Finance Inc. (“GrafTech Finance”) and GrafTech Global Enterprises Inc. (“GrafTech Global” and, together with GrafTech Finance, the “Issuers”), each a subsidiary of the Company. In the Exchange Offers, eligible holders had the opportunity to exchange their outstanding 4.625% senior secured notes due 2028 (the “4.625% No...
CompoSecure Earns Global Recognition in 2024 with 9 Awards and 11 Fina...
CompoSecure Earns Global Recognition in 2024 with 9 Awards and 11 Finalist Honors Honors for leadership, innovation, and excellence in payments and security solutions SOMERSET, N.J., Dec. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, was recognized with multiple prestigious awards and finalist honors during 2024. The company earned top distinctions across the banking, technology, manufacturing, finance, legal, and payment innovation sectors, highlighting its commitment to industry leadership on a global scale. “Wh...
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQ...
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced the successful completion of the first cases utilizing SpeedPlate™ ™ implants. The MicroQuad™ implant expands upon the broad utility of the SpeedPlate™ platform, which is desig...
GrafTech Earns Silver Medal from EcoVadis for Sustainability Performan...
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE:EAF) (“GrafTech” or the “Company”) today announced that it has earned a from EcoVadis, a global leader in business sustainability assessments. Awarded to the top 15% of companies that are assessed globally by EcoVadis, GrafTech’s rating is a reflection of the Company’s ongoing commitment to environmental, social, and governance (“ESG”) issues and promoting transparency throughout the value chain. This achievement demonstrates significant continuous improvement since receiving a bronze medal the previous year. “At Gr...
First Tap-to-Authenticate Report Released by PYMNTS Intelligence and A...
First Tap-to-Authenticate Report Released by PYMNTS Intelligence and Arculus by CompoSecure, Highlighting Top Security Concerns for Financial Institutions 87 percent of financial institutions report a rise in stolen credentials as fraud cases surge, according to new survey SOMERSET, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, released the industry’s first tap-to- authenticate report in collaboration with a leading payments analyst organization. The report identified the top security challenges facing ...
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient...
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced the successful completion of the first cases combining IntelliGuide™ PSI technology with the Ad...
Treace Appoints Guy Guglielmino as Chief Commercial Officer
Treace Appoints Guy Guglielmino as Chief Commercial Officer PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced that Guy Guglielmino joined the Company as Chief Commercial Officer. In this new position, Mr. Guglielmino will lead Treace’s commercial efforts and play a pivotal role in driving the Company’s next phase of rapid innovation,...
GrafTech Announces Commencement of Exchange Offers and Consent Solicit...
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) announced today that GrafTech Finance Inc. (“GrafTech Finance”) and GrafTech Global Enterprises Inc. (“GrafTech Global” and, together with GrafTech Finance, the “Issuers”), each a subsidiary of the Company, have commenced separate offers to exchange (each an “Exchange Offer” and, together, the “Exchange Offers”) any and all of (i) GrafTech Finance’s 4.625% senior secured notes due 2028 (the “Existing 4.625% Notes”) and (ii) GrafTech Global’s 9.875% senior secured notes due 2028 (the ...
Treace Announces Participation at Stifel 2024 Healthcare Conference
Treace Announces Participation at Stifel 2024 Healthcare Conference PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024, beginning at approxi...
GrafTech Reports Third Quarter 2024 Results
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) ("GrafTech," the "Company," "we," or "our") today announced unaudited financial results for the quarter and nine months ended September 30, 2024. In a separate press release, dated November 12, 2024, the Company also announced that it has entered into a commitment and consent letter (the "Commitment Letter") with lenders holding all of its existing revolving commitments and an ad hoc group that holds over 81% of its existing secured bonds to provide new debt financing on competitive terms and extend maturities of...
GrafTech Announces Agreement for New Capital to Bolster Liquidity
BROOKLYN HEIGHTS, Ohio--(BUSINESS WIRE)-- GrafTech International Ltd. (NYSE: EAF) (“GrafTech” or the “Company”) today announced that it has entered into a commitment and consent letter with lenders holding all of its existing revolving commitments, an ad hoc group that holds over 81% of its existing secured bonds to provide new debt financing on competitive terms and extend maturities of its existing debt, and Barclays Bank plc, as a fronting lender. Pursuant to the terms of the commitment and consent letter, GrafTech expects to (i) incur $175 million of new senior secured first lien term lo...
CompoSecure Reports Strong Third Quarter 2024 Financial Results
CompoSecure Reports Strong Third Quarter 2024 Financial Results Q3 Net Sales up 11% to $107.1 millionGAAP Net Income/(Loss) of $(85.5) million due to significant stock price improvement negatively impacting the fair value of non-cash itemsQ3 Adjusted Net Income up 18% to $25.6 millionQ3 Adjusted EBITDA up 13% to $40.0 millionCompleted ; appointed new Executive Chairman and Board membersRevises 2024 outlook: Net Sales guidance to range between $418-$424 million; Adjusted EBITDA guidance to range between $148-$151 million to reflect investments for future growth SOMERSET, N.J., Nov. 08, 202...
Cardlytics Announces Third Quarter 2024 Financial Results
Cardlytics Announces Third Quarter 2024 Financial Results ATLANTA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), a digital advertising platform, today announced financial results for the third quarter ended September 30, 2024. "Our third quarter results beat the high end of our guidance, which reflects our relentless focus on addressing our short-term challenges," said Amit Gupta, CEO of Cardlytics. "We maintain that our business transformation will take time, but we believe our priorities to build a more performant network and scale our partnerships will maximize co...
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
Treace Medical Concepts Reports Third Quarter 2024 Financial Results PONTE VEDRA, Fla., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Revenue of $45.1 million in third quarter 2024 increased 11% over same period in 2023Third quarter 2024 net loss was ($15.4) millio...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.